Status:
COMPLETED
Depiction of Prostate Cancer Treatment Alternatives in Greece
Lead Sponsor:
AstraZeneca
Conditions:
Locally Advanced or Metastatic Prostate Cancer.
Eligibility:
MALE
18+ years
Brief Summary
A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the ther...
Eligibility Criteria
Inclusion
- Patients diagnosed with Locally advanced or Metastatic Prostate Cancer after 2002.
- Patients that received Hormonal therapy.
Exclusion
- Males that are aged less than 18 years
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT00733213
Start Date
January 1 2008
End Date
March 1 2009
Last Update
October 14 2009
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Athens, Greece
2
Research Site
Karditsa, Greece
3
Research Site
Serres, Greece
4
Research Site
Xsanthi, Greece